Related Experiment Videos
Implantable middle ear hearing devices: Food and Drug Administration review process
1Ear, Nose, and Throat Devices Branch, United States Food and Drug Administration; and Drug Administration, Center for Devices and Radiological Health, Rockville, Maryland, USA.
Otolaryngologic Clinics of North America
|May 31, 2001
Summary
The Food and Drug Administration (FDA) reviews new implantable middle ear hearing devices to ensure patient and physician safety and effectiveness before market release.
Area of Science:
- Medical Devices
- Regulatory Science
- Otolaryngology
Background:
- The Food and Drug Administration (FDA) plays a critical role in safeguarding public health.
- Ensuring the safety and efficacy of medical devices is paramount before patient use.
Purpose of the Study:
- To provide an overview of the FDA's device review process.
- To detail the FDA's review specifically for implantable middle ear hearing devices.
Main Methods:
- Review of FDA regulatory guidelines and procedures.
- Analysis of the application of these procedures to implantable hearing devices.
Main Results:
- The FDA's primary function is to protect patients and healthcare providers.
- A structured review process assesses device safety and effectiveness.
Conclusions:
- The FDA's oversight is essential for the safe introduction of new medical technologies.
- Understanding the FDA review process is crucial for manufacturers and clinicians involved with implantable hearing devices.